NASDAQ:ALPN

Alpine Immune Sciences News Headlines

$11.07
+0.62 (+5.93 %)
(As of 04/14/2021 01:59 PM ET)
Add
Compare
Today's Range
$10.46
Now: $11.07
$11.12
50-Day Range
$10.02
MA: $11.96
$13.92
52-Week Range
$2.58
Now: $11.07
$16.37
Volume986 shs
Average Volume124,820 shs
Market Capitalization$264.37 million
P/E RatioN/A
Dividend YieldN/A
Beta1.72

Headlines

Alpine Immune Sciences (NASDAQ ALPN) News Headlines Today

SourceHeadline
Alpine Immune Sciences (NASDAQ:ALPN) Stock Rating Reaffirmed by OppenheimerAlpine Immune Sciences (NASDAQ:ALPN) Stock Rating Reaffirmed by Oppenheimer
marketbeat.com - March 19 at 4:24 AM
Alpine Immune Sciences Presents Clinical and Preclinical Oncology Program Updates at AACR Virtual Annual Meeting IAlpine Immune Sciences Presents Clinical and Preclinical Oncology Program Updates at AACR Virtual Annual Meeting I
finance.yahoo.com - April 12 at 12:23 PM
Investors Buy Large Volume of Put Options on Alpine Immune Sciences (NASDAQ:ALPN)Investors Buy Large Volume of Put Options on Alpine Immune Sciences (NASDAQ:ALPN)
americanbankingnews.com - April 7 at 2:16 PM
Announcing: Alpine Immune Sciences (NASDAQ:ALPN) Stock Increased An Energizing 296% In The Last YearAnnouncing: Alpine Immune Sciences (NASDAQ:ALPN) Stock Increased An Energizing 296% In The Last Year
nasdaq.com - April 6 at 6:05 PM
Alpine Immune Sciences, Inc. (NASDAQ:ALPN) Expected to Announce Quarterly Sales of $5.84 MillionAlpine Immune Sciences, Inc. (NASDAQ:ALPN) Expected to Announce Quarterly Sales of $5.84 Million
americanbankingnews.com - April 3 at 2:56 AM
 Brokerages Anticipate Alpine Immune Sciences, Inc. (NASDAQ:ALPN) to Announce -$0.28 EPS Brokerages Anticipate Alpine Immune Sciences, Inc. (NASDAQ:ALPN) to Announce -$0.28 EPS
americanbankingnews.com - April 1 at 12:16 PM
Alpine Immune Sciences, Inc. (NASDAQ:ALPN) Sees Large Increase in Short InterestAlpine Immune Sciences, Inc. (NASDAQ:ALPN) Sees Large Increase in Short Interest
americanbankingnews.com - April 1 at 1:14 AM
Research Analysts Issue Forecasts for Alpine Immune Sciences, Inc.s Q1 2021 Earnings (NASDAQ:ALPN)Research Analysts Issue Forecasts for Alpine Immune Sciences, Inc.'s Q1 2021 Earnings (NASDAQ:ALPN)
americanbankingnews.com - March 25 at 7:56 AM
Wedbush Comments on Alpine Immune Sciences, Inc.s Q2 2021 Earnings (NASDAQ:ALPN)Wedbush Comments on Alpine Immune Sciences, Inc.'s Q2 2021 Earnings (NASDAQ:ALPN)
americanbankingnews.com - March 24 at 8:54 AM
Alpine Immune Sciences, Inc. (NASDAQ:ALPN) Receives Consensus Recommendation of "Buy" from BrokeragesAlpine Immune Sciences, Inc. (NASDAQ:ALPN) Receives Consensus Recommendation of "Buy" from Brokerages
americanbankingnews.com - March 22 at 5:16 PM
Oppenheimer Comments on Alpine Immune Sciences, Inc.s FY2025 Earnings (NASDAQ:ALPN)Oppenheimer Comments on Alpine Immune Sciences, Inc.'s FY2025 Earnings (NASDAQ:ALPN)
americanbankingnews.com - March 22 at 3:00 AM
Alpine Immune Sciences (NASDAQ:ALPN) Is Using Debt SafelyAlpine Immune Sciences (NASDAQ:ALPN) Is Using Debt Safely
finance.yahoo.com - March 21 at 8:43 AM
Why Alpine Immune Sciences Is Trading Lower TodayWhy Alpine Immune Sciences Is Trading Lower Today
msn.com - March 19 at 2:10 PM
Alpine Immune Sciences, Inc. (ALPN) Reports Q4 Loss, Tops Revenue EstimatesAlpine Immune Sciences, Inc. (ALPN) Reports Q4 Loss, Tops Revenue Estimates
finance.yahoo.com - March 19 at 9:10 AM
Alpine Immune Sciences, Inc. (ALPN) Q4 2020 Earnings Call TranscriptAlpine Immune Sciences, Inc. (ALPN) Q4 2020 Earnings Call Transcript
fool.com - March 19 at 12:37 AM
Alpine Immune Sciences to Report Fourth Quarter and Full Year 2020 Financial Results and Provide Corporate UpdateAlpine Immune Sciences to Report Fourth Quarter and Full Year 2020 Financial Results and Provide Corporate Update
finance.yahoo.com - March 11 at 7:30 PM
Alpine Immune Sciences Highlights Poster Presentations At American Association For Cancer Research Apr. 10Alpine Immune Sciences Highlights Poster Presentations At American Association For Cancer Research Apr. 10
benzinga.com - March 10 at 11:33 PM
Alpine Immune Sciences Announces Poster Presentations at AACR Virtual Annual Meeting IAlpine Immune Sciences Announces Poster Presentations at AACR Virtual Annual Meeting I
finance.yahoo.com - March 10 at 6:32 PM
Alpine Immune Sciences to Participate in Upcoming Virtual Healthcare ConferencesAlpine Immune Sciences to Participate in Upcoming Virtual Healthcare Conferences
finance.yahoo.com - February 22 at 7:12 PM
Investors Who Bought Alpine Immune Sciences (NASDAQ:ALPN) Shares A Year Ago Are Now Up 318%Investors Who Bought Alpine Immune Sciences (NASDAQ:ALPN) Shares A Year Ago Are Now Up 318%
finance.yahoo.com - February 4 at 7:41 AM
Alpine Immune Sciences Announces Executive Leadership Addition and PromotionAlpine Immune Sciences Announces Executive Leadership Addition and Promotion
finance.yahoo.com - January 6 at 8:15 AM
Need To Know: Alpine Immune Sciences, Inc. (NASDAQ:ALPN) Insiders Have Been Buying SharesNeed To Know: Alpine Immune Sciences, Inc. (NASDAQ:ALPN) Insiders Have Been Buying Shares
finance.yahoo.com - December 21 at 7:49 AM
Alpine Immune Sciences to Present at 39th Annual J.P. Morgan Healthcare ConferenceAlpine Immune Sciences to Present at 39th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - December 17 at 12:41 PM
Is ALPN A Good Stock To Buy Now?Is ALPN A Good Stock To Buy Now?
finance.yahoo.com - December 12 at 12:19 AM
Alpine Immune Sciences Appoints Natasha Hernday to Board of DirectorsAlpine Immune Sciences Appoints Natasha Hernday to Board of Directors
finance.yahoo.com - December 11 at 9:18 AM
Alpine (ALPN) Looks Good: Stock Adds 7.8% in SessionAlpine (ALPN) Looks Good: Stock Adds 7.8% in Session
finance.yahoo.com - December 8 at 6:00 PM
Alpine Immune Sciences to Participate in Fireside Chat at the Evercore ISI 3rd Annual HealthCONx Virtual ConferenceAlpine Immune Sciences to Participate in Fireside Chat at the Evercore ISI 3rd Annual HealthCONx Virtual Conference
finance.yahoo.com - November 24 at 6:29 PM
Independent Director Robert Conway Just Bought 67% More Shares In Alpine Immune Sciences, Inc. (NASDAQ:ALPN)Independent Director Robert Conway Just Bought 67% More Shares In Alpine Immune Sciences, Inc. (NASDAQ:ALPN)
nasdaq.com - November 24 at 8:19 AM
Alpine Immune Sciences to Participate in Fireside Chat at the Piper Sandler 32nd Annual Virtual Healthcare ConferenceAlpine Immune Sciences to Participate in Fireside Chat at the Piper Sandler 32nd Annual Virtual Healthcare Conference
finance.yahoo.com - November 16 at 6:58 PM
Analyst Estimates: Heres What Brokers Think Of Alpine Immune Sciences, Inc. (NASDAQ:ALPN) After Its Third-Quarter ReportAnalyst Estimates: Here's What Brokers Think Of Alpine Immune Sciences, Inc. (NASDAQ:ALPN) After Its Third-Quarter Report
finance.yahoo.com - November 15 at 12:35 PM
Alpine Immune Sciences EPS misses by $0.05, misses on revenueAlpine Immune Sciences EPS misses by $0.05, misses on revenue
seekingalpha.com - November 12 at 8:14 PM
Alpine Immune Sciences, Inc. (ALPN) CEO Mitchell Gold on Q3 2020 Results - Earnings Call TranscriptAlpine Immune Sciences, Inc. (ALPN) CEO Mitchell Gold on Q3 2020 Results - Earnings Call Transcript
seekingalpha.com - November 12 at 8:14 PM
Alpine Immune Sciences Reports Third Quarter 2020 Financial Results and Provides Corporate UpdateAlpine Immune Sciences Reports Third Quarter 2020 Financial Results and Provides Corporate Update
finance.yahoo.com - November 12 at 8:14 PM
Alpine Immune Sciences to Report Third Quarter 2020 Financial Results and Provide Corporate UpdateAlpine Immune Sciences to Report Third Quarter 2020 Financial Results and Provide Corporate Update
finance.yahoo.com - November 5 at 7:08 PM
How Much Is Alpine Immune Sciences, Inc. (NASDAQ:ALPN) CEO Getting Paid?How Much Is Alpine Immune Sciences, Inc. (NASDAQ:ALPN) CEO Getting Paid?
finance.yahoo.com - October 28 at 9:20 AM
Alpine Immune Sciences to Present at Oppenheimer Fall Healthcare Life Sciences & MedTech SummitAlpine Immune Sciences to Present at Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
finance.yahoo.com - September 15 at 5:42 PM
Alpine Immune Sciences Inc (ALPN.OQ)Alpine Immune Sciences Inc (ALPN.OQ)
in.reuters.com - September 9 at 5:00 PM
Alpine Immune Sciences, Inc. (ALPN) CEO Mitchell Gold on Q2 2020 Results - Earnings Call TranscriptAlpine Immune Sciences, Inc. (ALPN) CEO Mitchell Gold on Q2 2020 Results - Earnings Call Transcript
seekingalpha.com - August 12 at 3:22 AM
Alpine Immune Sciences Reports Second Quarter 2020 Financial Results and Provides Corporate UpdateAlpine Immune Sciences Reports Second Quarter 2020 Financial Results and Provides Corporate Update
finance.yahoo.com - August 11 at 4:39 PM
Alpine Immune Sciences to Present at 2020 Wedbush PacGrow Healthcare Virtual ConferenceAlpine Immune Sciences to Present at 2020 Wedbush PacGrow Healthcare Virtual Conference
finance.yahoo.com - August 5 at 5:32 PM
Alpine Immune Sciences to Report Second Quarter 2020 Financial Results and Provide Corporate UpdateAlpine Immune Sciences to Report Second Quarter 2020 Financial Results and Provide Corporate Update
finance.yahoo.com - August 4 at 8:53 PM
Alpine Immune Sciences secures equity capital of $60MAlpine Immune Sciences secures equity capital of $60M
seekingalpha.com - July 24 at 1:10 PM
Alpine Immune Sciences Announces $60 Million Private PlacementAlpine Immune Sciences Announces $60 Million Private Placement
finance.yahoo.com - July 24 at 1:10 PM
Did Business Growth Power Alpine Immune Sciences (NASDAQ:ALPN) Share Price Gain of 126%?Did Business Growth Power Alpine Immune Sciences' (NASDAQ:ALPN) Share Price Gain of 126%?
finance.yahoo.com - July 22 at 7:21 AM
Did Business Growth Power Alpine Immune Sciences' (NASDAQ:ALPN) Share Price Gain of 126%?Did Business Growth Power Alpine Immune Sciences' (NASDAQ:ALPN) Share Price Gain of 126%?
finance.yahoo.com - July 22 at 7:21 AM
Keep an eye on the price momentum at Alpine Immune Sciences IncKeep an eye on the price momentum at Alpine Immune Sciences Inc
uk.finance.yahoo.com - July 20 at 9:56 AM
Alpine Immune Sciences, Inc. (ALPN) Shares March Higher, Can It Continue?Alpine Immune Sciences, Inc. (ALPN) Shares March Higher, Can It Continue?
finance.yahoo.com - July 8 at 9:32 AM
BRIEF-Alpine Immune Sciences And Abbvie Announce Option And License Agreement For Development And Commercialization Of ALPN-101BRIEF-Alpine Immune Sciences And Abbvie Announce Option And License Agreement For Development And Commercialization Of ALPN-101
www.reuters.com - June 26 at 7:28 AM
Alpine Begins Dosing in Phase I Study for Advanced MalignanciesAlpine Begins Dosing in Phase I Study for Advanced Malignancies
finance.yahoo.com - June 25 at 3:22 PM
Alpine Immune Sciences reports NEON-1 Phase 1 trial of ALPN-202Alpine Immune Sciences reports NEON-1 Phase 1 trial of ALPN-202
seekingalpha.com - June 24 at 1:23 PM
Alpine Immune Sciences doses first patient in Phase 1 study of ALPN-202Alpine Immune Sciences doses first patient in Phase 1 study of ALPN-202
seekingalpha.com - June 24 at 1:23 PM
This page was last updated on 4/14/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.